A Study to Test How Well a Medicine Called Nintedanib Helps People in China With Progressive Lung Fibrosis

Clinical trial NCT05065190 · COMPLETED

Trial details

NCT number: NCT05065190
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Diseases, Interstitial

Start date: 2021-11-25
Primary completion: 2024-04-30
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.